HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Strides Pharma Science’s arm incorporates company in New Zealand
Jul-27-2024

Strides Pharma Science’s step-down wholly owned subsidiary--Strides Pharma Global Pte, Singapore, has incorporated a company in New Zealand in the name of ‘Strides Pharma New Zealand’ on July 26, 2024. Strides New Zealand shall hold market authorizations for the products in New Zealand and shall also undertake trading in pharmaceutical products.

Strides Group has a diverse portfolio of products across various therapeutic categories, which are fungible to be commercialized in several regions/ markets. Strides New Zealand was incorporated to leverage the existing product portfolio from US, UK, Australia and other regulated markets to register and sell these products in New Zealand; and to have a local presence to ensure seamless interactions with the Government for participating in local tenders amongst other activities.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules. 


  RELATED NEWS >>